Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock transcription factor Y-linked 6, pseudogene (HSFY6P), is a non-functional pseudogene homolog of heat shock transcription factors on the Y chromosome. **Pseudogenes** like HSFY6P are DNA sequences similar to known functional genes but carry mutations that prevent the production of a functional protein[2][4]. Most pseudogenes, including likely HSFY6P, are not transcribed or translated, but some can have regulatory roles if expressed as non-coding RNA[2][4]. **HSFY6P** is not considered a therapeutic target, as it does not code for a protein, nor does it have established biomarker or disease roles. Its main relevance is as a genomic relic reflecting the evolutionary dynamics of the heat shock factor family. There are no known drugs or therapeutic mechanisms associated with HSFY6P. **Key context and rationale:** - This entry is a **pseudogene**, not a receptor, enzyme, transporter, or canonical therapeutic target[2][4]. - There is no evidence of protein expression, ligand binding, or active biological function associated with HSFY6P. - Pseudogenes like HSFY6P are typically excluded from drug development pipelines and are not considered in therapeutic targeting frameworks. - If novel roles are discovered for HSFY6P (e.g., as a regulatory RNA), those would require new, cited primary literature—none was identified in the current results. **Errors/Limitations:** - HSFY6P is sometimes mis-annotated or misrepresented as a functional gene; it is in fact a pseudogene and not an actionable drug target. - There is no evidence for it being a receptor or for any drugs interacting with it. - If evaluating for a drug targeting or receptor discovery database, this entry should be flagged as "incorrect" for those uses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock transcription factor Y-linked 6, pseudogene (HSFY6P).